Cycloset

Product manufactured by Santarus, Inc.

Application Nr Approved Date Route Status External Links
NDA020866 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cycloset Is A Dopamine Receptor Agonist Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 , 11 ) Important Limitations Of Use: Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1.2 ) Limited Efficacy Data In Combination With Thiazolidinediones. ( 1.2 ) Efficacy Has Not Been Confirmed In Combination With Insulin. ( 1.2 ) 1.1 Type 2 Diabetes Mellitus Cycloset Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. 1.2 Important Limitations Of Use Cycloset Should Not Be Used To Treat Type 1 Diabetes Or Diabetic Ketoacidosis. Limited Efficacy Data In Combination With Thiazolidinediones. Efficacy Has Not Been Confirmed In Combination With Insulin.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bromocriptine Mesylate BROMOCRIPTINE MESYLATE ZINC53683151

Comments